| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.09 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.087 | 0.09 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.09 |